These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 546338)

  • 1. [Induction of pulmonary thrombosis in mice, rabbits and hamsters by intravenous injection of arachidonic acid. Comparative study of 3 experimental models in vivo and the antithrombotic activity of triflusal].
    García Rafanell J; Bellés L; Forn J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):193-8. PubMed ID: 546338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of pulmonary thrombosis in the rat by i.v. injections of ADP and the antithrombotic activity of triflusal].
    Ramis J; Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1982 Dec; 8(3):111-6. PubMed ID: 7183241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of chronic administration of triflusal on pulmonary thrombosis induced by arachidonic acid].
    Ramis J; Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1982 Dec; 8(3):117-22. PubMed ID: 6820762
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous arachidonate-induced respiratory distress: comparative study of three in vivo models for the measurement of antithrombotic activity.
    Garcia Rafanell J; Forn J
    J Pharmacol Methods; 1982 May; 7(3):231-8. PubMed ID: 6810027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis.
    Lijnen HR; Stassen JM; Vanlinthout I; Fukao H; Okada K; Matsuo O; Collen D
    Thromb Haemost; 1991 Oct; 66(4):468-73. PubMed ID: 1796398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs.
    Kohler C; Wooding W; Ellenbogen L
    Thromb Res; 1976 Jul; 9(1):67-80. PubMed ID: 960063
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models.
    Hara H; Kitajima A; Shimada H; Tamao Y
    Thromb Haemost; 1991 Oct; 66(4):484-8. PubMed ID: 1796400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lauric acid-induced thrombocytopenia and thrombosis in rabbits.
    Zbinden G
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):57-65. PubMed ID: 6066605
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of triflusal and acetylsalicylic acid against arachidonic acid induced cerebrovascular occlusion in anesthetized rats.
    Gómez L; García Rafanell J; Forn J
    Methods Find Exp Clin Pharmacol; 1987 Jan; 9(1):13-7. PubMed ID: 3106730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
    Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
    Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Arachidonic acid and platelet aggregation.
    Furlow TW
    Lancet; 1974 Nov; 2(7888):1080. PubMed ID: 4138267
    [No Abstract]   [Full Text] [Related]  

  • 12. Baboon models of acute arterial thrombosis.
    Hanson SR; Harker LA
    Thromb Haemost; 1987 Oct; 58(3):801-5. PubMed ID: 3324380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An onion variety has natural antithrombotic effect as assessed by thrombosis/thrombolysis models in rodents.
    Yamada K; Naemura A; Sawashita N; Noguchi Y; Yamamoto J
    Thromb Res; 2004; 114(3):213-20. PubMed ID: 15342218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
    Lorrain J; Millet L; Lechaire I; Lochot S; Ferrari P; Visconte C; Sainte-Marie M; Lunven C; Berry CN; Schaeffer P; Herbert JM; O'Connor SE
    J Pharmacol Exp Ther; 2003 Feb; 304(2):567-74. PubMed ID: 12538808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombotic action of benzydamine].
    Jansen JW
    Arzneimittelforschung; 1987 May; 37(5A):626-8. PubMed ID: 3619983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid causes sudden death in rabbits.
    Silver MJ; Hoch W; Kocsis JJ; Ingerman CM; Smith JB
    Science; 1974 Mar; 183(4129):1085-7. PubMed ID: 4812036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous and aerosolized arachidonic acid on alveolar epithelial permeability in rabbits.
    Stevenson JL; Quan SF; Witten ML; Hall JN; Roseberry HR; McNeill GC; Lemen RJ
    Res Commun Chem Pathol Pharmacol; 1991 Apr; 72(1):113-6. PubMed ID: 1905059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental models of arterial thrombosis].
    Aguejouf O; Imbault P; Jourdan A; Doutremepuich F; Juaneda M; Doutremepuich C
    Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):109-18. PubMed ID: 7793848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic activity of para-aminobenzoic acid].
    Drozd NN; Makarov VA; Miftakhova NT; Kalugin SA; Stroeva OG; Akberova SI
    Eksp Klin Farmakol; 2000; 63(3):40-4. PubMed ID: 10934595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.